Jiangsu Synthgene Biotechnology Co., Ltd.
PrivateLast Round
Series B
Nov 10, 2021
Total Funding Raised
$174.7M
Company Overview
Jiangsu Synthgene Biotechnology Co., Ltd. is a biotechnology company that provides upstream raw materials and solutions for life sciences, including mRNA, oligonucleotide, and cell and gene therapy manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Advanced Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu Synthgene Biotechnology Co., Ltd. Comparables
Compare Jiangsu Synthgene Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yeasen Biotechnology (Shanghai) Co., Ltd. | 54% | |
| Hongene Biotechnology | 52% | |
| Novoprotein Scientific Inc. | 49% |
Jiangsu Synthgene Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 10, 2021 | ||||
| Series A Extension | Dec 1, 2020 | ||||
| Series A Extension | Nov 11, 2020 | ||||
| Series A | Sep 6, 2020 | ||||
| VC Round | Jun 20, 2019 | ||||
Angel | May 22, 2018 |
Key People
Founding team and executive leadership
Jiangsu Synthgene Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lake Bleu Capital | Series B |
| MSA Capital | Series B |
| ARCH Venture Partners | Series B, Series A |
| Frees Fund | VC Round, Angel |
| Chenling Capital | Series B, Series A Extension |
| Lilly Asia Ventures | Series B, Series A Extension, Series A |
| Superstring Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2021
$100M round led by Lake Bleu Capital.
- Sep 6, 2020
$30M round led by Lilly Asia Ventures.
Jiangsu Synthgene Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Jiangsu Synthgene Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Jiangsu Synthgene Biotechnology Co., Ltd. a public or private company?
Jiangsu Synthgene Biotechnology Co., Ltd. is a private company.
What is the current stock price of Jiangsu Synthgene Biotechnology Co., Ltd.?
Jiangsu Synthgene Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Jiangsu Synthgene Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Jiangsu Synthgene Biotechnology Co., Ltd. is not publicly available.
Can I buy Jiangsu Synthgene Biotechnology Co., Ltd. stock?
Jiangsu Synthgene Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Jiangsu Synthgene Biotechnology Co., Ltd.'s last funding round?
Jiangsu Synthgene Biotechnology Co., Ltd.'s most recent funding round was Series B on November 10, 2021.
Who are the main investors in Jiangsu Synthgene Biotechnology Co., Ltd.?
Key investors in Jiangsu Synthgene Biotechnology Co., Ltd. include Lake Bleu Capital, Lilly Asia Ventures, Oriza Seed Venture Capital, Sherpa Healthcare Partners.
Will Jiangsu Synthgene Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Jiangsu Synthgene Biotechnology Co., Ltd..
How can I track Jiangsu Synthgene Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Jiangsu Synthgene Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.